DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Park W, Yoo DH, Jaworski J. et al.
Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study.
Arthritis Res Ther 2016;
18: 25
We do not assume any responsibility for the contents of the web pages of other providers.